Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


New Products In Brief

This article was originally published in The Tan Sheet

Executive Summary

Xenergy touts difference: Xyience acknowledges it is launching its energy drink in a crowded and rapidly growing market, but the firm says its product provides what the competition is "lacking when it comes to taste and nutrition." Calorie-free Xenergy provides both rapid and long-lasting energy by adding glucoronolactone to boost the effects of the caffeine in the ingredients, says Las Vegas-based Xyience, which also markets nutritional bars and supplements. The drink also includes B vitamins and metabolism boosters. Xyience says Dec. 11 it is launching Xenergy in retail stores in states in the west, mid-west and southeast. It is available in "Clear," "Big Apple" and "Cran/Razz" flavors in 8.4-oz cans with MSRP of $2.19 and in 16-oz cans at $2.79...

You may also be interested in...

Reducol approved by EU

Forbes Medi-Tech's Reducol has been deemed "substantially equivalent" for seven new food groups by European regulatory authorities, the firm announces March 2. The cholesterol-lowering ingredient was approved by the European Union Standing Commission on the Food Chain & Animal Health for use in margarine-type products, milk-based products and soy drinks. Forbes Medi-Tech says the "functional food solution" is meant for people with mildly high cholesterol or statin-sensitive consumers. New products containing the ingredient are in development and product claims are not finalized at this time, the company states. Reducol is licensed in the U.S. by Pharmavite in its NatureMade Cholest-Off supplement...

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

People In Brief

Perrigo promotes in pricing, planning





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts